Vasoactive Intestinal Peptide (VIP) is an intriguing neuropeptide with a wide range of potential biological impacts, primarily hypothesized in tissues, cells, and internal systems. Since its discovery ...
Sol-Gel reported a net loss of $0.4 million for the third quarter of 2024 and loss of $0.01 per basic and diluted share, compared to a net loss of $5.7 million and a loss of $0.21 per basic and ...
Research peptides, short chains of amino acids believed to mimic naturally occurring proteins, have emerged as promising compounds across diverse fields of scientific inquiry. Their potential to influ ...